Familial Hypercholesterolemia, as an Independent Risk of Cerebral Small Vessel Disease
Stroke · 2025
DOI: 10.1161/strokeaha.124.050070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stroke, 2025. Verfasst von Hiroaki Murata und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology (H.M., Y.H., K. Noda, M.I.), National Cerebral and Cardiovascular Center, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Familial hypercholesterolemia (FH) is characterized by elevated levels of LDL-C (low-density lipoprotein cholesterol) since birth. However, the association between FH and cerebrovascular diseases, including cerebral small vessel disease (CSVD), is controversial. To investigate the association between FH and CSVD, we compared the prevalence and severity of CSVD neuroradiological findings between patients with FH and control participants. METHODS: Patients with FH who visited the lipid clinic and underwent brain magnetic resonance imaging at the National Cerebral and Cardiovascular Center in Japan from November 2006 to April 2021 and control participants who voluntarily underwent brain magnetic resonance imaging as a checkup between December 2000 and December 2010 at the Health Science Center Shimane, Japan, were enrolled into the study. The prevalence and severity of CSVD neuroradiological findings were investigated in patients with FH and control participants, and potential risk factors for CSVD development were identified using multivariable logistic and quasi-Poisson regression analyses. RESULTS: A total of 151 patients with FH and 3172 control participants were enrolled in this study. FH was identified as an independent risk factor of prevalent lacunes (adjusted odds ratio, 1.60 [95% CI, 1.03–2.51]; P =0.039) and increased number of lacunes (1.67 times [95% CI, 1.17–2.31]; P =0.003). Furthermore, FH was also an independent risk factor of prevalent cerebral microbleeds (adjusted odds ratio, 9.42 [95% CI, 5.81–15.28]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology (H.M., Y.H., K. Noda, M.I.), National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Preemptive Medicine for Dementia (Y.H.), National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan (M.H.).
- Department of Preventive Medicine and Epidemiology (S.O., Y.N., K. Nishimura), National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Radiology (Y.M.), National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
- Department of Neurology, Shimane University School of Medicine, Izumo, Shimane, Japan (A.N.).
ORCID-Profile: Yorito Hattori, Kotaro Noda, Mika Hori, Soshiro Ogata, Yuriko Nakaoku, Yoshiaki Morita, Kunihiro Nishimura, Atsushi Nagai, Shuhei Yamaguchi, Masafumi Ihara
Zitieren
APA
Murata, H., Hattori, Y., Noda, K., Hori, M., Ogata, S., Nakaoku, Y., Morita, Y., Nishimura, K., Nagai, A., Harada-Shiba, M., Yamaguchi, S., & Ihara, M. (2025). Familial Hypercholesterolemia, as an Independent Risk of Cerebral Small Vessel Disease. Stroke. https://doi.org/10.1161/strokeaha.124.050070
Vancouver
Murata H, Hattori Y, Noda K, Hori M, Ogata S, Nakaoku Y, et al. Familial Hypercholesterolemia, as an Independent Risk of Cerebral Small Vessel Disease. Stroke. 2025. doi:10.1161/strokeaha.124.050070
BibTeX
@article{Murata2025,
author = {Murata, Hiroaki and Hattori, Yorito and Noda, Kotaro and Hori, Mika and Ogata, Soshiro and Nakaoku, Yuriko and Morita, Yoshiaki and Nishimura, Kunihiro and Nagai, Atsushi and Harada-Shiba, Mariko and Yamaguchi, Shuhei and Ihara, Masafumi},
title = {Familial Hypercholesterolemia, as an Independent Risk of Cerebral Small Vessel Disease},
journal = {Stroke},
year = {2025},
doi = {10.1161/strokeaha.124.050070}
}
EUVIMED